GLA
AKTS

Great Lakes Advisors’s Aktis Oncology AKTS Stock Holding History

Great Lakes Advisors’s Portfolio AKTS Stock Details AKTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41M Buy
+43,612
New +$896K 0.01% 477

Other funds holding AKTS

BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Great Lakes Advisors's AKTS Position: Q2 2026 in Review

Great Lakes Advisors opened a new position in Aktis Oncology (AKTS) in Q2 2026: 43,612 shares worth $1.41M. The stake represents 0.01% of the portfolio and ranks #477 among its holdings.

47 funds tracked by Wall St. Rank hold AKTS as of Q2 2026.

  • Great Lakes Advisors held 43,612 shares of Aktis Oncology worth $1.41M as of Q2 2026.
  • Aktis Oncology was a new Great Lakes Advisors position in Q2 2026.
  • Aktis Oncology made up 0.01% of Great Lakes Advisors's portfolio in Q2 2026, its #477 holding.
  • 47 funds tracked by Wall St. Rank held Aktis Oncology as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.